Collateral benefit
33 An issue arose as to whether a collateral benefit accrued to the shareholders of Contact, who either have a direct or indirect interest in URB, as a result of the Contact Transaction. As noted above, this issue was the subject of detailed correspondence between URB and ASIC. A related issue also arose (discussed below) as to whether the terms of the Contact Transaction are such as to create a separate class of URB shareholders for the purpose of convening separate scheme meetings.
34 The issue of collateral benefit was considered in Re David Jones Ltd (No 2) (2014) 101 ACSR 381; [2014] FCA 720 (David Jones (No 2)) and in David Jones Ltd, in the matter of David Jones Ltd (No 3) [2014] FCA 753 (David Jones (No 3)). In that case notice had been given after the first court hearing that Mr Lew was a substantial shareholder in David Jones Ltd. Relevantly, the bidder had also announced that it would make a bid for all of the remaining shares in Country Road Ltd, of which Mr Lew owned 11.8%. That bid was subject to the scheme proposed by David Jones Ltd being approved and taking effect. In David Jones (No 2) at [18]-[19] Farrell J said:
18. The offering of a collateral benefit designed to induce a shareholder to accept a takeover bid conducted under Ch 6 of the Corporations Act or to dispose of shares in the same class as those the subject of a bid would be prohibited under s 623(1). In its consideration of whether unacceptable circumstances may exist, the takeovers panel looks at whether a bidder provides a security holder something of value which it does not offer to other security holders: see Takeovers Panel Guidance Note 21: Collateral Benefits at [5].
19. Although there is no equivalent provision to s 623 relating to schemes of arrangement effected under s 411 of the Corporations Act, it is ASIC's policy to have regard to these principles in relation to a scheme effecting a change of control: see ASIC Regulatory Guide 60 Schemes of Arrangement (RG 60) at [RG 60.18]. ASIC says to do otherwise has the potential to undermine the integrity of the scheme procedure as a method of effecting a control transaction.
35 At [30]-[31] her Honour referred to the practice of providing an additional expert report when an issue of collateral benefit may arise as follows:
30. ASIC's primary concerns are substantial matters. Where an issue emerges of whether a shareholder in a scheme company may receive some benefit different from other shareholders if the scheme is approved, the best information for shareholders or the court in considering whether to approve the scheme is an appropriately qualified independent expert's report which identifies the nature and extent of the benefit.
31. It is for this reason that it has become usual for proponents of a scheme which may benefit a shareholder, director or other related party differently from other scheme participants to provide an expert's report concerning the nature and extent of the likely benefit at the first court hearing to assist the court in making orders convening a scheme meeting under s 411(1). iSOFT, Texon and Aston are all cases of this kind. The court did not require the provision of the report in those cases, it was proffered. It is undoubtedly logistically easiest to arrange for an expert's report at the time of the first court hearing and it is appropriate that it occur then (where it is possible) so that shareholders have time to consider any issues before they vote. However, while provision of an expert's report may be the best way to satisfy the court on this issue, it does not mean that it is the only way.
36 RG 60 at RG 60.23 provides that ASIC will closely consider a scheme if:
(1) some holders in a class of security in the target (Target Security) receive a collateral benefit in connection with the scheme; or
(2) there are collateral benefits associated with the consideration offered for each different class of Target Security (whether that consideration is offered under the scheme or under a separate agreement between the acquirer and the holder of the Target Security).
37 In David Jones (No 3) at [12]-[13] Farrell J observed that:
12 Both David Jones and ASIC made submissions concerning when a "collateral benefit" may be taken to exist by reason of the Country Road Bid. It is unnecessary in these reasons to canvas in detail the technicalities which are called into consideration in determining this issue under s 623 of the Corporations Act, breach of which is an offence or may give rise to "unacceptable circumstances". The transaction under consideration is a scheme of arrangement to which s 623 does not apply. The relevance of the principles set out in s 602 goes to the question of fairness and the desirability of there being, so far as relevant and possible, neutrality between "acquisition" schemes and Chapter 6 takeovers.
13 However, one of the reasons for the continued existence of the s 411 avenue for effecting mergers is that it is a flexible way of accommodating differences in the treatment of shareholders. It is for this reason that it is not illegal for a collateral benefit to be offered or given. Nor is it necessarily inappropriate for there to be differential consideration or collateral benefits subject to how the related questions of fairness and adequacy of disclosure to shareholders who will not participate in a benefit are addressed. The "fairness" issue is usually dealt with in one of two ways: first, by deciding whether there are differences which are "class creating" or, second (and arguably more appropriately where the issue is collateral benefits), by enquiring whether processes have been established by the scheme company to "tag" votes of interested shareholders or for interested shareholders to abstain from voting. Either approach allows appropriately informed shareholders who will not share in a benefit to determine the outcome of the approval resolution and prevents shareholders with greater bargaining power from being advantaged over shareholders with less bargaining power without the consent of the less powerful shareholders.
38 The facts relating to the Contact Transaction are set out at [14]-[24] above. The Independent Expert has provided an opinion on the market value of the management rights under the IMA and whether a net benefit is being provided and concluded that the Contact Transaction represents the receipt by Contact of a net benefit when measured by reference to the market value of the management rights as required by Takeovers Panel Guidance Note 21: Collateral Benefits (TPGN21). In David Jones (No 3) at [15] Farrell J accepted that the appropriate measure of whether a benefit exists is the net benefits test adopted in TPGN21 in determining whether unacceptable circumstances exist because of the existence of such an interest. Her Honour continued:
15 … This test was posited by Santow J in Boral Energy Resources Ltd v TU Australia (Queensland) Pty Ltd (1998) 43 NSWLR 638 at 680:
The preferred holistic view instead takes into account whatever rights or benefits are conferred by each transaction, to be netted off against whatever rights or benefits are thereby given up, to the extent such benefits are commensurable at least in an approximate sense. The resultant net benefit is to be compared under each transaction. Only if there is overall disparity in favour of the party to the non-bid transaction is s 698(1) [now s 623] contravened. This is in the sense of a balance of advantage, profit or good in favour of the party to the non-bid transaction.
16 I also accept that, as contemplated by GN 21 at [32], there may be "inducement" arising from collateral benefits which should be taken into account where there is no material "net benefit" but a shareholder is offered the opportunity to acquire or dispose of an asset for which there is no ready market or easily ascertainable value.
39 There are a number of factors that are relevant to a consideration of whether a collateral benefit arises in the context of the Contact Transaction.
40 First, as already observed, the evidence establishes that the negotiations for the Contact Transaction were at arm's length, did not involve the board of URB and the price that 360 Capital Group is prepared to pay reflects its view as to the value of the management rights, notwithstanding that that value is higher than the value determined by the Independent Expert.
41 Secondly, URB accepts that the benefits that may flow indirectly to entities controlled by Messrs Millner and Culbert may not be de minimis relative to the value of the shareholding in URB held by other entities controlled by those gentlemen. For that reason, and following discussion with ASIC, Mr Millner, TOMCIL and Culbert W&E have entered into deed polls and will not vote at the Scheme Meeting. Relevant parties not voting is an appropriate course to adopt in the circumstances: see David Jones (No 3) at [13] (at [37] above).
42 Thirdly, the position of WHSP is different. It will vote at the Scheme Meeting. As the evidence establishes, it has a 12.35% interest in URB valued at approximately $10m. Contact is receiving a sale price for the management rights which, according to the Independent Expert, exceeds their market value by $600,000 to $1.2m. URB submitted, and I accepted, that having regard to WHSP's shareholding in Contact the benefit which may indirectly flow to it, relative to its 12.35% shareholding in URB, is de minimis: approximately $120,000-$240,000 for the Novation Price and an unspecified amount, likely to be no more than $60,000, in respect of the Transitional Services Fee. There are two further relevant aspects to WHSP's position: as URB observed, it is not known whether the full amount of the Novation Price will be distributed by Contact to its shareholders, given that Contact will continue to be an operating business following implementation of the Scheme; and WHSP's votes will be tagged at the Scheme Meeting.
43 Finally, the Contact Transaction was disclosed in the Scheme Booklet and, subject to one amendment made as a result of the first court hearing, I was satisfied that the transaction and its effect is fully and properly disclosed in the Scheme Booklet.